Worldwide Primary Cells Industry to 2025 - Featuring Zenbio, Stem Cell Technologies & Allcells Among Others Dublin, Oct. 12, 2020 (GLOBE NEWSWIRE) -- The "Primary Cells Market by Origin (Human Primary Cells, Animal Primary Cells), Type (Hematopoietic, Dermatocytes, Gastrointestinal, Hepatocytes, Lung,...

Visiongain states that "Translational regenerative medicine market set to grow to $76bn by 2023". London, UK, March 28, 2019 (GLOBE NEWSWIRE) -- The high potential earning for companies from products aimed at repairing organs and tissues has led to an increase in the attention given to...

Visiongain launches new report on Gene Therapy R&D and Revenue Forecasts 2018-2028 LONDON, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Gene Therapy Market set to Grow at a CAGR of 41.1% in the first half of the forecast period. Visiongain has launched a new pharma report: Gene Therapy...

Visiongain Launches Global Translational Regenerative Medicine Market Prospects 2017-2027: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies LONDON, Nov. 14, 2017 (GLOBE NEWSWIRE) -- The translational regenerative medicine market has been undergoing considerable changes over the last few years. There are a number of therapies that have...